Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sarah Boross-Harmer

Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Related publications

Minimally Invasive Liver Resection to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in Patients With Metastatic Melanoma

World Journal of Surgical Oncology
SurgeryOncology
2012English

Efficacy of Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2012English

Treatment With Tumour Infiltrating Lymphocytes and Interleukin-2 in Patients With Metastatic Melanoma: A Pilot Study

Biotherapy
1992English

Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes Against Metastatic Liver Tumors.

Acta Hepatologica Japonica
Hepatology
1989English

A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2002English

Phase I/Ii Trial of Melanoma Therapy With Dendritic Cells Transfected With Autologous Tumor-mRNA

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine With Aldesleukin (Interleukin 2) and IFN- 2a Therapy in Metastatic Renal Cell Carcinoma Patients

Clinical Cancer Research
Cancer ResearchOncology
2009English

A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy